HLTH Communications

HLTH Communications is a Public Relations and Investors Relations agency specialized in the HLTH sector.

[HLTH Communications @HLTH_Comms]

Another strong month of media coverage for our clients across biotech, healthcare, longevity, telehealth, psychedelics, and critical minerals.

Interested in elevating your company's visibility?

📩 Let's connect.
#PublicRelations #InvestorRelations #MediaRelations #HealthcarePR

[HLTH Communications @HLTH_Comms]

On this week's episode, we sit down with Dr. Tyler Evans, physician, global health leader, author, and CEO of Wellness Equity Alliance, for a powerful conversation about the social, political, and economic forces that shape health around the world.
Listen https://t.co/hfULWASgl9

[HLTH Communications @HLTH_Comms]

Client Coverage Spotlight: Enveric (NASDAQ: ENVB) Featured in Labiotech. As mental health innovation accelerates, Enveric’s work on non-hallucinogenic neuroplastogens like EB-003 continues to stand out in the evolving psychiatric treatment landscape.
🔗 https://t.co/dUP9TZnSXo

[HLTH Communications @HLTH_Comms]

When policy shifts, positioning matters. Dr. Robert Discordia of Equulus was featured on @cgtnamerica discussing the FDA’s fast-tracking of psychedelic treatments and the broader implications for mental healthcare. https://t.co/cbSa7iH1BW #HLTHCommunications #BiotechPR

[HLTH Communications @HLTH_Comms]

🎉 Happy New Year from HLTH Communications 🎉

Thank you to our cleints for trusting us to help shape your story, whether through strategy, storytelling, or standing out in a crowded space. Your bold ideas and unwavering vision continue to inspire everything we do.

[HLTH Communications @HLTH_Comms]

🎄✨ Happy Holidays from HLTH Communications ✨🎄

To our incredible clients, collaborators, and friends, thank you for trusting us with your stories, your science, and your boldest ambitions this year.

#HappyHolidays #Gratitude #CheersTo2026 #HealthInnovation #BiotechFamily

[HLTH Communications @HLTH_Comms]

As the biotech world looks back on 2025, Labiotech takes stock of the year’s biggest modality shifts and strategic bets—and we’re excited to share that our own Natalie Dolphin was featured in the piece!
🔗 Read the full retrospective
https://t.co/shJ1s890S9

[HLTH Communications @HLTH_Comms]

🎙️ The Business of HLTH Podcast: 2025 Wrapped
What. A. Year. Thanks to you, our community of founders, operators, and investors, we had our biggest year yet. From bold biotech plays to health tech moonshots, S2 was a wild ride—and S3 lands Jan 7, 2026. Set your calendar.

[HLTH Communications @HLTH_Comms]

A great media win for our client Enveric. This Meditech Today feature digs into the new wave of psychedelic inspired medicine and why non hallucinogenic neuroplastogens are gaining serious traction with researchers and investors.

Full article here: https://t.co/ICnnT2JWJV

[HLTH Communications @HLTH_Comms]

A new feature is out highlighting the vital role Canada’s critical metals sector plays in supporting the global shift to cleaner energy.

Check out the full article: https://t.co/b5r1r9Co8f

#CriticalMinerals #EnergyTransition #CleanEnergy #MiningInCanada #Exploration #StrategX

[HLTH Communications @HLTH_Comms]

Enveric shared that it received a fourth NoA for its EVM401 series, adding to its growing intellectual property around nonhallucinogenic neuroplastogenic compounds.

Check out the full article here: https://t.co/CIbSUn1BjX

#biotechnews #drugdevelopment $ENVB

[HLTH Communications @HLTH_Comms]

We’re proud to see Darren Bahrey of StrategX Elements Corp. featured in The Epoch Times in the article titled “The Strategy That Could Help U.S. Decouple From China’s Rare Earths.”

🔗 Read the full piece: The Epoch Times
https://t.co/Trz0Wbplmp

#StrategXElements #RareEarths

[HLTH Communications @HLTH_Comms]

Natalie recently sat down with Authority Magazine to talk about how emerging health and biotech startups are changing the game, and how our team helps them build visibility, attract investors, and tell stories that truly move markets.
https://t.co/aCfPQLC7Zs

[HLTH Communications @HLTH_Comms]

In today’s complex funding landscape, investors are more discerning than ever and that means how you tell your biotech story matters just as much as what you’re building.
Investors don’t just fund science they fund conviction.
Read the full article here ➡️ https://t.co/Tcm5XlIdYZ

[HLTH Communications @HLTH_Comms]

HLTH in the Headlines
We’re thrilled to see our Co-Founder & Managing Partner, Natalie Dolphin, featured in Authority Magazine! Read the full piece: “Startup Revolution: How Emerging Startup Clients Are Changing the Game”

👉 https://t.co/aCfPQLC7Zs

#StartupPR #BiotechComms

[HLTH Communications @HLTH_Comms]

Main stage moments at #HLTH2025

So many incredible conversations about the future of healthcare, digital therapeutics, and biotech innovation.

Are you attending? Come say hi! #HLTHConference #HLTHComms #Biotech

[HLTH Communications @HLTH_Comms]

We’ve landed in Vegas! 🎰✨
The team is at #HLTH2025 this week. Ready to meet, mingle, and talk all things health innovation, biotech, and wellness.

If you spot us, come say hi (we don’t bite 😄).

[HLTH Communications @HLTH_Comms]

We’re proud to see Enveric Biosciences (NASDAQ: ENVB) featured in Clinical Leader, offering a behind-the-scenes look at how the company is preparing for its first IND submission and clinical entry for lead candidate EB-003.

🔗 Read the full feature:
https://t.co/D5tdu4EX7m

[HLTH Communications @HLTH_Comms]

Excited to share that I’ll be attending #HLTH2025 this Oct 19–22 in Vegas!
From cutting-edge biotech breakthroughs to the future of digital health, #HLTHUSA is where the healthcare ecosystem comes to connect, collaborate, and drive real impact.
Let’s meet https://t.co/f2VlsvxXdq

[HLTH Communications @HLTH_Comms]

Enveric Biosciences (NASDAQ: ENVB) is making headlines on https://t.co/NqVZwXPWfE for taking a bold stand to protect its IP—right in the wake of AbbVie’s $1.2B acquisition of Bretisilocin.

https://t.co/NhtlnvoxV1
#BiotechNews #AbbVie #GilgameshPharma #IntellectualProperty $ENVB